CSX CSX Corporation

0.50.5P6Mfalse--12-31Q1202000002779480.240.2611P10Y 0000277948 2020-01-01 2020-03-31 0000277948 2020-03-31 0000277948 2019-01-01 2019-03-31 0000277948 2019-12-31 0000277948 csx:AffiliatesAndOtherCompaniesMember 2019-12-31 0000277948 csx:AffiliatesAndOtherCompaniesMember 2020-03-31 0000277948 csx:InvestmentsInJointVenturesMember 2020-03-31 0000277948 csx:InvestmentsInJointVenturesMember 2019-12-31 0000277948 2018-12-31 0000277948 2019-03-31 0000277948 us-gaap:RetainedEarningsMember 2020-01-01 2020-03-31 0000277948 us-gaap:CommonStockMember 2019-12-31 0000277948 us-gaap:CommonStockIncludingAdditionalPaidInCapitalMember 2020-03-31 0000277948 us-gaap:CommonStockIncludingAdditionalPaidInCapitalMember 2020-01-01 2020-03-31 0000277948 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2020-03-31 0000277948 us-gaap:CommonStockMember 2020-01-01 2020-03-31 0000277948 us-gaap:NoncontrollingInterestMember 2020-03-31 0000277948 us-gaap:NoncontrollingInterestMember 2019-12-31 0000277948 us-gaap:CommonStockIncludingAdditionalPaidInCapitalMember 2019-12-31 0000277948 us-gaap:RetainedEarningsMember 2020-03-31 0000277948 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2020-01-01 2020-03-31 0000277948 us-gaap:CommonStockMember 2020-03-31 0000277948 us-gaap:RetainedEarningsMember 2019-12-31 0000277948 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2019-12-31 0000277948 us-gaap:NoncontrollingInterestMember 2020-01-01 2020-03-31 0000277948 us-gaap:CommonStockMember 2019-01-01 2019-03-31 0000277948 us-gaap:CommonStockIncludingAdditionalPaidInCapitalMember 2019-01-01 2019-03-31 0000277948 us-gaap:RetainedEarningsMember 2019-01-01 2019-03-31 0000277948 us-gaap:RetainedEarningsMember 2019-03-31 0000277948 us-gaap:CommonStockIncludingAdditionalPaidInCapitalMember 2018-12-31 0000277948 us-gaap:CommonStockMember 2019-03-31 0000277948 us-gaap:CommonStockMember 2018-12-31 0000277948 us-gaap:RetainedEarningsMember 2018-12-31 0000277948 us-gaap:NoncontrollingInterestMember 2019-03-31 0000277948 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2019-03-31 0000277948 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2018-12-31 0000277948 us-gaap:CommonStockIncludingAdditionalPaidInCapitalMember 2019-03-31 0000277948 us-gaap:NoncontrollingInterestMember 2018-12-31 0000277948 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2019-01-01 2019-03-31 0000277948 us-gaap:EmployeeStockOptionMember 2019-01-01 2019-03-31 0000277948 2020-02-12 2020-02-12 0000277948 csx:ShareRepurchaseProgramOctober2017Member 2017-10-31 0000277948 us-gaap:EmployeeStockOptionMember 2020-01-01 2020-03-31 0000277948 csx:ShareRepurchaseProgramJanuary2019Member 2020-03-31 0000277948 csx:ShareRepurchaseProgramOctober2017Member 2018-02-28 0000277948 csx:ShareRepurchaseProgramJanuary2019Member 2019-01-31 0000277948 csx:LongtermIncentivePlanMember 2020-02-18 2020-02-18 0000277948 us-gaap:EmployeeStockMember csx:EmployeeStockPurchasePlanMember 2019-01-01 2019-03-31 0000277948 us-gaap:EmployeeStockOptionMember csx:LongtermIncentivePlanMember 2020-02-18 2020-02-18 0000277948 us-gaap:EmployeeStockMember csx:EmployeeStockPurchasePlanMember 2018-05-31 2018-05-31 0000277948 us-gaap:EmployeeStockMember csx:EmployeeStockPurchasePlanMember 2018-05-31 0000277948 us-gaap:EmployeeStockMember csx:EmployeeStockPurchasePlanMember 2020-01-01 2020-03-31 0000277948 srt:MinimumMember us-gaap:PerformanceSharesMember csx:LongtermIncentivePlanMember 2020-02-18 2020-02-18 0000277948 csx:CertainEmployeesMember us-gaap:PerformanceSharesMember csx:LongtermIncentivePlanMember 2020-02-18 2020-02-18 0000277948 srt:MaximumMember srt:ExecutiveOfficerMember us-gaap:PerformanceSharesMember csx:LongtermIncentivePlanMember 2020-02-18 2020-02-18 0000277948 srt:MaximumMember us-gaap:PerformanceSharesMember csx:LongtermIncentivePlanMember 2020-02-18 2020-02-18 0000277948 srt:ExecutiveOfficerMember us-gaap:PerformanceSharesMember csx:LongtermIncentivePlanMember 2020-02-18 2020-02-18 0000277948 us-gaap:RestrictedStockUnitsRSUMember csx:LongtermIncentivePlanMember 2020-02-18 2020-02-18 0000277948 us-gaap:PerformanceSharesMember csx:LongtermIncentivePlanMember 2020-02-18 2020-02-18 0000277948 csx:PerformanceUnitsMember 2020-01-01 2020-03-31 0000277948 csx:PerformanceUnitsMember 2019-01-01 2019-03-31 0000277948 us-gaap:EmployeeStockMember 2019-01-01 2019-03-31 0000277948 us-gaap:PerformanceSharesMember 2019-01-01 2019-03-31 0000277948 us-gaap:EmployeeStockOptionMember 2020-01-01 2020-03-31 0000277948 us-gaap:EmployeeStockOptionMember 2019-01-01 2019-03-31 0000277948 csx:StockAwardsDirectorsMember 2020-01-01 2020-03-31 0000277948 csx:StockAwardsDirectorsMember 2019-01-01 2019-03-31 0000277948 us-gaap:PerformanceSharesMember 2020-01-01 2020-03-31 0000277948 us-gaap:EmployeeStockMember 2020-01-01 2020-03-31 0000277948 us-gaap:RestrictedStockUnitsRSUMember 2020-01-01 2020-03-31 0000277948 us-gaap:RestrictedStockUnitsRSUMember 2019-01-01 2019-03-31 0000277948 csx:OtherReservesMember 2020-03-31 0000277948 csx:TotalCasualtyMember 2019-12-31 0000277948 us-gaap:EnvironmentalIssueMember 2019-12-31 0000277948 csx:OtherReservesMember 2019-12-31 0000277948 csx:PersonalInjuryCasualtyMember 2020-03-31 0000277948 csx:PersonalInjuryCasualtyMember 2019-12-31 0000277948 us-gaap:EnvironmentalIssueMember 2020-03-31 0000277948 csx:TotalCasualtyMember 2020-03-31 0000277948 csx:OccupationalCasualtyMember 2020-03-31 0000277948 csx:OccupationalCasualtyMember 2019-12-31 0000277948 csx:TotalCasualtyMember 2020-01-01 2020-03-31 0000277948 csx:EnvironmentalLitigationMember 2016-03-31 0000277948 csx:EnvironmentalLitigationMember 2020-01-01 2020-03-31 0000277948 csx:EnvironmentalLitigationMember us-gaap:SettledLitigationMember 2016-03-01 2016-03-31 0000277948 srt:MaximumMember 2020-03-31 0000277948 csx:EnvironmentalLitigationMember 2018-06-30 2018-06-30 0000277948 csx:FuelSurchargeAntitrustLitigationMember 2007-05-01 2007-05-31 0000277948 csx:FuelSurchargeAntitrustLitigationMember us-gaap:PendingLitigationMember 2007-05-01 2007-05-31 0000277948 srt:MaximumMember us-gaap:PendingLitigationMember 2020-03-31 0000277948 srt:MinimumMember us-gaap:PendingLitigationMember 2020-03-31 0000277948 srt:MinimumMember 2020-03-31 0000277948 us-gaap:PensionPlansDefinedBenefitMember 2019-01-01 2019-03-31 0000277948 us-gaap:OtherPostretirementBenefitPlansDefinedBenefitMember 2019-01-01 2019-03-31 0000277948 us-gaap:OtherPostretirementBenefitPlansDefinedBenefitMember 2020-01-01 2020-03-31 0000277948 us-gaap:PensionPlansDefinedBenefitMember 2020-01-01 2020-03-31 0000277948 us-gaap:OtherPostretirementBenefitPlansDefinedBenefitMember 2020-01-01 2020-01-01 0000277948 us-gaap:OtherPostretirementBenefitPlansDefinedBenefitMember 2019-01-01 2019-01-01 0000277948 csx:LongTermLiabilitiesMember 2020-01-01 2020-03-31 0000277948 csx:LongTermLiabilitiesMember 2020-03-31 0000277948 csx:CurrentLiabilitiesMember 2019-12-31 0000277948 csx:CurrentLiabilitiesMember 2020-01-01 2020-03-31 0000277948 csx:LongTermLiabilitiesMember 2019-12-31 0000277948 csx:CurrentLiabilitiesMember 2020-03-31 0000277948 us-gaap:RevolvingCreditFacilityMember csx:UnsecuredRevolvingCreditFacilityDue2024Member 2020-03-31 0000277948 csx:A3.80NotesDue2050Member 2020-03-30 0000277948 us-gaap:CommercialPaperMember 2020-03-31 0000277948 csx:CoalServicesMember 2019-01-01 2019-03-31 0000277948 csx:FertilizersMember 2019-01-01 2019-03-31 0000277948 csx:CoalServicesMember 2020-01-01 2020-03-31 0000277948 csx:AgriculturalandFoodProductsMember 2020-01-01 2020-03-31 0000277948 csx:AgriculturalandFoodProductsMember 2019-01-01 2019-03-31 0000277948 csx:ChemicalsMember 2020-01-01 2020-03-31 0000277948 csx:MetalsandEquipmentMember 2019-01-01 2019-03-31 0000277948 csx:ForestProductsMember 2020-01-01 2020-03-31 0000277948 csx:TotalMerchandiseMember 2020-01-01 2020-03-31 0000277948 csx:AutomotiveMember 2019-01-01 2019-03-31 0000277948 csx:ChemicalsMember 2019-01-01 2019-03-31 0000277948 csx:ForestProductsMember 2019-01-01 2019-03-31 0000277948 csx:MetalsandEquipmentMember 2020-01-01 2020-03-31 0000277948 csx:IntermodalMember 2020-01-01 2020-03-31 0000277948 csx:FertilizersMember 2020-01-01 2020-03-31 0000277948 csx:MineralsMember 2019-01-01 2019-03-31 0000277948 csx:TotalMerchandiseMember 2019-01-01 2019-03-31 0000277948 csx:OtherServicesMember 2020-01-01 2020-03-31 0000277948 csx:AutomotiveMember 2020-01-01 2020-03-31 0000277948 csx:MineralsMember 2020-01-01 2020-03-31 0000277948 csx:OtherServicesMember 2019-01-01 2019-03-31 0000277948 csx:IntermodalMember 2019-01-01 2019-03-31 0000277948 srt:MaximumMember 2020-01-01 2020-03-31 0000277948 srt:MinimumMember 2020-01-01 2020-03-31 0000277948 csx:NonFreightReceivablesMember 2020-03-31 0000277948 csx:FreightReceivablesMember 2019-12-31 0000277948 csx:NonFreightReceivablesMember 2019-12-31 0000277948 csx:FreightReceivablesMember 2020-03-31 0000277948 us-gaap:FairValueInputsLevel2Member us-gaap:CarryingReportedAmountFairValueDisclosureMember 2020-03-31 0000277948 us-gaap:FairValueInputsLevel2Member us-gaap:EstimateOfFairValueFairValueDisclosureMember 2019-12-31 0000277948 us-gaap:FairValueInputsLevel2Member us-gaap:CarryingReportedAmountFairValueDisclosureMember 2019-12-31 0000277948 us-gaap:FairValueInputsLevel2Member us-gaap:EstimateOfFairValueFairValueDisclosureMember 2020-03-31 0000277948 us-gaap:EstimateOfFairValueFairValueDisclosureMember 2019-12-31 0000277948 us-gaap:EstimateOfFairValueFairValueDisclosureMember 2020-03-31 0000277948 us-gaap:CarryingReportedAmountFairValueDisclosureMember 2019-12-31 0000277948 us-gaap:FairValueInputsLevel2Member us-gaap:EstimateOfFairValueFairValueDisclosureMember us-gaap:CashEquivalentsMember 2019-12-31 0000277948 us-gaap:CarryingReportedAmountFairValueDisclosureMember 2020-03-31 0000277948 us-gaap:FairValueInputsLevel2Member us-gaap:EstimateOfFairValueFairValueDisclosureMember us-gaap:CorporateBondSecuritiesMember 2020-03-31 0000277948 us-gaap:FairValueInputsLevel2Member us-gaap:EstimateOfFairValueFairValueDisclosureMember us-gaap:CashEquivalentsMember 2020-03-31 0000277948 us-gaap:FairValueInputsLevel2Member us-gaap:EstimateOfFairValueFairValueDisclosureMember us-gaap:CorporateBondSecuritiesMember 2019-12-31 0000277948 us-gaap:FairValueInputsLevel2Member us-gaap:EstimateOfFairValueFairValueDisclosureMember us-gaap:USTreasuryAndGovernmentMember 2019-12-31 0000277948 us-gaap:FairValueInputsLevel2Member us-gaap:EstimateOfFairValueFairValueDisclosureMember us-gaap:USTreasuryAndGovernmentMember 2020-03-31 0000277948 csx:AccumulatedOtherAdjustmentstoParentMember 2020-01-01 2020-03-31 0000277948 csx:AccumulatedOtherAdjustmentstoParentMember 2020-03-31 0000277948 us-gaap:AccumulatedDefinedBenefitPlansAdjustmentMember 2020-01-01 2020-03-31 0000277948 us-gaap:AccumulatedDefinedBenefitPlansAdjustmentMember 2019-12-31 0000277948 us-gaap:AccumulatedDefinedBenefitPlansAdjustmentMember 2020-03-31 0000277948 csx:AccumulatedOtherAdjustmentstoParentMember 2019-12-31 0000277948 srt:SubsidiariesMember 2019-01-01 2019-03-31 0000277948 srt:SubsidiariesMember 2020-01-01 2020-03-31 0000277948 srt:ParentCompanyMember 2019-01-01 2019-03-31 0000277948 srt:ConsolidationEliminationsMember 2019-01-01 2019-03-31 0000277948 srt:ConsolidationEliminationsMember 2020-01-01 2020-03-31 0000277948 srt:ParentCompanyMember 2020-01-01 2020-03-31 0000277948 srt:ConsolidationEliminationsMember 2020-03-31 0000277948 srt:ParentCompanyMember 2020-03-31 0000277948 srt:SubsidiariesMember 2020-03-31 0000277948 srt:SubsidiariesMember csx:AffiliatesAndOtherCompaniesMember 2020-03-31 0000277948 srt:ConsolidationEliminationsMember us-gaap:InvestmentsInMajorityOwnedSubsidiariesMember 2020-03-31 0000277948 srt:ParentCompanyMember csx:InvestmentsInJointVenturesMember 2020-03-31 0000277948 srt:SubsidiariesMember csx:InvestmentsInJointVenturesMember 2020-03-31 0000277948 srt:ConsolidationEliminationsMember csx:AffiliatesAndOtherCompaniesMember 2020-03-31 0000277948 srt:ConsolidationEliminationsMember csx:InvestmentsInJointVenturesMember 2020-03-31 0000277948 srt:ParentCompanyMember csx:AffiliatesAndOtherCompaniesMember 2020-03-31 0000277948 srt:SubsidiariesMember us-gaap:InvestmentsInMajorityOwnedSubsidiariesMember 2020-03-31 0000277948 us-gaap:InvestmentsInMajorityOwnedSubsidiariesMember 2020-03-31 0000277948 srt:ParentCompanyMember us-gaap:InvestmentsInMajorityOwnedSubsidiariesMember 2020-03-31 0000277948 srt:ParentCompanyMember 2019-12-31 0000277948 srt:ConsolidationEliminationsMember 2019-12-31 0000277948 srt:SubsidiariesMember 2019-12-31 0000277948 srt:ConsolidationEliminationsMember csx:InvestmentsInJointVenturesMember 2019-12-31 0000277948 srt:ConsolidationEliminationsMember us-gaap:InvestmentsInMajorityOwnedSubsidiariesMember 2019-12-31 0000277948 srt:ParentCompanyMember us-gaap:InvestmentsInMajorityOwnedSubsidiariesMember 2019-12-31 0000277948 srt:ParentCompanyMember csx:AffiliatesAndOtherCompaniesMember 2019-12-31 0000277948 srt:ConsolidationEliminationsMember csx:AffiliatesAndOtherCompaniesMember 2019-12-31 0000277948 srt:SubsidiariesMember csx:InvestmentsInJointVenturesMember 2019-12-31 0000277948 srt:SubsidiariesMember us-gaap:InvestmentsInMajorityOwnedSubsidiariesMember 2019-12-31 0000277948 us-gaap:InvestmentsInMajorityOwnedSubsidiariesMember 2019-12-31 0000277948 srt:ParentCompanyMember csx:InvestmentsInJointVenturesMember 2019-12-31 0000277948 srt:SubsidiariesMember csx:AffiliatesAndOtherCompaniesMember 2019-12-31 0000277948 srt:ConsolidationEliminationsMember 2019-03-31 0000277948 srt:SubsidiariesMember 2018-12-31 0000277948 srt:ParentCompanyMember 2018-12-31 0000277948 srt:SubsidiariesMember 2019-03-31 0000277948 srt:ParentCompanyMember 2019-03-31 0000277948 srt:ConsolidationEliminationsMember 2018-12-31 csx:defendant utreg:mi csx:claim csx:site csx:entity iso4217:USD xbrli:shares xbrli:shares xbrli:pure csx:state iso4217:USD csx:party

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

WASHINGTON, D.C. 20549

FORM 10-Q

 

For the quarterly period ended March 31, 2020

OR

(☐)    TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

Certain prior year data has been reclassified to conform to the current presentation.

See accompanying notes to consolidated financial statements.

CSX CORPORATION

ITEM 1. FINANCIAL STATEMENTS

CONSOLIDATED STATEMENTS OF CHANGES

IN SHAREHOLDERS' EQUITY

(Dollars in Millions)

(a) Accumulated Other Comprehensive Loss balances shown above are net of tax. The associated taxes were $183 million and $179 million as of March 31, 2020 and March 31, 2019, respectively. For additional information, see Note 12, Other Comprehensive Income.

See accompanying notes to consolidated financial statements.

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS

(Unaudited)

NOTE 1.Nature of Operations and Significant Accounting Policies

Background

CSX Corporation together with its subsidiaries ("CSX" or the “Company”), based in Jacksonville, Florida, is one of the nation's leading transportation companies. The Company provides rail-based transportation services including traditional rail service, the transport of intermodal containers and trailers, as well as other transportation services such as rail-to-truck transfers and bulk commodity operations.

CSX's principal operating subsidiary, CSX Transportation, Inc. (“CSXT”), provides an important link to the transportation supply chain through its approximately 20,000 route mile rail network, which serves major population centers in 23 states east of the Mississippi River, the District of Columbia and the Canadian provinces of Ontario and Quebec. The Company's intermodal business links customers to railroads via trucks and terminals.

CSXT is also responsible for the Company's real estate sales, leasing, acquisition and management and development activities. Substantially all of these activities are focused on supporting railroad operations.

Other entities

In addition to CSXT, the Company’s subsidiaries include CSX Intermodal Terminals, Inc. (“CSX Intermodal Terminals”), Total Distribution Services, Inc. (“TDSI”), Transflo Terminal Services, Inc. (“Transflo”), CSX Technology, Inc. (“CSX Technology”) and other subsidiaries. CSX Intermodal Terminals owns and operates a system of intermodal terminals, predominantly in the eastern United States and also performs drayage services (the pickup and delivery of intermodal shipments) for certain customers and trucking dispatch operations. TDSI serves the automotive industry with distribution centers and storage locations. Transflo connects non-rail served customers to the many benefits of rail by transferring products from rail to trucks. The biggest Transflo markets are chemicals and agriculture, which includes shipments of plastics and ethanol. CSX Technology and other subsidiaries provide support services for the Company.

    

Basis of Presentation

In the opinion of management, the accompanying consolidated financial statements contain all normal, recurring adjustments necessary to fairly present the consolidated financial statements and accompanying notes. Where applicable, prior year information has been reclassified to conform to the current presentation. Pursuant to the rules and regulations of the Securities and Exchange Commission (“SEC”), certain information and disclosures normally included in the notes to the annual financial statements prepared in accordance with U.S. generally accepted accounting principles (“GAAP”) have been omitted from these interim financial statements. CSX suggests that these financial statements be read in conjunction with the audited financial statements and the notes included in CSX's most recent annual report on Form 10-K and any subsequently filed current reports on Form 8-K.

Fiscal Year

The Company's fiscal periods are based upon the calendar year. Except as otherwise specified, references to “first quarter(s)” or “three months” indicate CSX's fiscal periods ending March 31, 2020 and March 31, 2019, and references to "year-end" indicate the fiscal year ended December 31, 2019.

New Accounting Pronouncements

In June 2016, the FASB issued ASU Measurement of Credit Losses on Financial Instruments, which replaces current methods for evaluating impairment of financial instruments not measured at fair value, including trade accounts receivable and certain debt securities, with a current expected credit loss model. CSX adopted this new standard update effective January 1, 2020, and it did not have a material effect on the Company's results of operations.

CSX CORPORATION

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS

(Unaudited)

NOTE 2.    Earnings Per Share

The following table sets forth the computation of basic earnings per share and earnings per share, assuming dilution:

Basic earnings per share is based on the weighted-average number of shares of common stock outstanding. Earnings per share, assuming dilution, is based on the weighted-average number of shares of common stock outstanding and common stock equivalents adjusted for the effects of common stock that may be issued as a result of potentially dilutive instruments. CSX's potentially dilutive instruments are made up of equity awards including performance units and employee stock options.

When calculating diluted earnings per share, the potential shares that would be outstanding if all outstanding stock options were exercised are included. This number is different from outstanding stock options because it is offset by shares CSX could repurchase using the proceeds from these hypothetical exercises to obtain the common stock equivalent. Approximately 1.4 million and 600 thousand of total average outstanding stock options for the quarters ended March 31, 2020 and March 31, 2019, respectively, were excluded from the diluted earnings per share calculation because their effect was antidilutive.

NOTE 2.    Earnings Per Share, continued

Share repurchases may be made through a variety of methods including, but not limited to, open market purchases, purchases pursuant to Rule 10b5-1 plans, accelerated share repurchases and negotiated block purchases. The timing of share repurchases depends upon management's assessment of marketplace conditions and other factors, and the program remains subject to the discretion of the Board of Directors. Future share repurchases are expected to be funded by cash on hand, cash generated from operations and debt issuances. Shares are retired immediately upon repurchase. In accordance with the Equity Topic in the Accounting Standards Codification ("ASC"), the excess of repurchase price over par value is recorded in retained earnings.

    

Dividend Increase

On February 12, 2020, the Company's Board of Directors authorized an 8% increase in the quarterly cash dividend to $0.26 per common share.

NOTE 3.     Stock Plans and Share-Based Compensation

Under CSX's share-based compensation plans, awards consist of performance units, stock options, restricted stock units and restricted stock awards for management and stock grants for directors. Awards granted under the various programs are determined and approved by the Compensation and Talent Management Committee of the Board of Directors or, in certain circumstances, by the full Board for awards to the Chief Executive Officer and by the Chief Executive Officer for awards to management employees other than senior executives. The Board of Directors approves awards granted to CSX's non-management directors upon recommendation of the Governance Committee.

Share-based compensation expense for awards under share-based compensation plans and purchases made as part of the employee stock purchase plan is measured using the fair value of the award on the grant date and is recognized on a straight-line basis over the service period of the respective award or upon grant date to certain retirement-eligible employees whose agreements allow for continued vesting upon retirement. Forfeitures are recognized as they occur. Total pre-tax expense and income tax benefits associated with share-based compensation are shown in the table below. Income tax benefits include impacts from option exercises and the vesting of other equity awards.

NOTE 3.     Stock Plans and Share-Based Compensation, continued

Long-term Incentive Plan

On February 18, 2020, the Company granted 218 thousand performance units to certain employees under a new long-term incentive plan ("LTIP") for the years 2020 through 2022, which was adopted under the CSX 2019 Stock and Incentive Award Plan.

Payouts of performance units for the cycle ending with fiscal year 2022 will be based on the achievement of goals related to both operating income and free cash flow, in each case excluding non-recurring items as disclosed in the Company's financial statements. The cumulative operating income and cumulative free cash flow measures over the plan period will each comprise 50% of the payout and will be measured independently of the other.

Grants were made in performance units, with each unit representing the right to receive one share of CSX common stock, and payouts will be made in CSX common stock. The payout range for participants will be between 0% and 200% of the target awards depending on Company performance against predetermined goals. Payouts for certain executive officers are subject to formulaic upward or downward adjustment by up to 25%, capped at an overall payout of 250%, based upon the Company's total shareholder return relative to specified comparable groups over the performance period. Participants will receive stock dividend equivalents declared over the performance period based on the number of performance units paid upon vesting. During first quarters 2020 and 2019, there were additional immaterial grants of performance units to members of management. The fair values of the performance units awarded during the quarters ended March 31, 2020 and March 31, 2019 were primarily calculated using a Monte-Carlo simulation model with the following weighted-average assumptions:

Stock Options

On February 18, 2020, the Company granted approximately 1.3 million stock options along with the corresponding LTIP. The fair value of stock options on the date of grant was $18.88 per option, which was calculated using the Black-Scholes valuation model. These stock options were granted with ten-year terms and vest over three years in equal installments each year on the anniversary of the grant date. The exercise price for stock options granted equals the closing market price of the underlying stock on the date of grant. These awards are time-based and are not based upon attainment of performance goals. During first quarters 2020 and 2019, there were additional immaterial grants of stock options to certain members of management.

CSX CORPORATION

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS

(Unaudited)

NOTE 3.     Stock Plans and Share-Based Compensation, continued

The fair values of all stock option awards during the quarters ended March 31, 2020 and March 31, 2019 were estimated at the grant date with the following weighted average assumptions:

Restricted Stock Units

On February 18, 2020, the Company granted 91 thousand restricted stock units along with the corresponding LTIP. The restricted stock units vest three years after the date of grant. Participants will receive stock dividend equivalents on the vested shares upon vesting. These awards are time-based and are not based upon CSX's attainment of operational targets. Restricted stock units are paid-out in CSX common stock on a one-for-one basis. For information related to the Company's other outstanding long-term incentive compensation, see CSX's most recent annual report on Form 10-K.

Employee Stock Purchase Plan

In May 2018, shareholders approved the 2018 CSX Employee Stock Purchase Plan (“ESPP”) for the benefit of Company employees. The Company registered 4 million shares of common stock that may be issued pursuant to this plan. Under the ESPP, employees may contribute between 1% and 10% of base compensation, after-tax, to purchase up to $25,000 of market value CSX common stock per year at 85% of the closing market price on either the grant date or the last day of the six-month offering period, whichever is lower. During first quarter ended March 31, 2020 and March 31, 2019, 122 thousand and 105 thousand shares of CSX stock were issued at a weighted average purchase price of $61.51 and $52.81 per share, respectively.

CSX CORPORATION

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS

(Unaudited)

NOTE 4.    Casualty, Environmental and Other Reserves

Personal injury and environmental reserves are considered critical accounting estimates due to the need for management judgment. Casualty, environmental and other reserves are provided for in the consolidated balance sheets as shown in the table below.

These liabilities are accrued when probable and reasonably estimable in accordance with the Contingencies Topic in the ASC. Actual settlements and claims received could differ, and final outcomes of these matters cannot be predicted with certainty. Considering the legal defenses currently available, the liabilities that have been recorded and other factors, it is the opinion of management that none of these items individually, when finally resolved, will have a material adverse effect on the Company's financial condition, results of operations or liquidity. Should a number of these items occur in the same period, however, their combined effect could be material in that particular period.

Casualty

Casualty reserves of $189 million and $187 million as of March 31, 2020 and December 31, 2019, respectively, represent accruals for personal injury, occupational disease and occupational injury claims. The Company's self-insured retention amount for these claims is $75 million per occurrence. Currently, no individual claim is expected to exceed the self-insured retention amount. In accordance with the Contingencies Topic in the ASC, to the extent the value of an individual claim exceeds the self-insured retention amount, the Company would present the liability on a gross basis with a corresponding receivable for insurance recoveries. These reserves fluctuate based upon the timing of payments as well as changes in estimate. Actual results may vary from estimates due to the number, type and severity of the injury, costs of medical treatments and uncertainties in litigation. Most of the Company's casualty claims relate to CSXT. Defense and processing costs, which historically have been insignificant and are anticipated to be insignificant in the future, are not included in the recorded liabilities.

Personal Injury

Personal injury reserves represent liabilities for employee work-related and third-party injuries. Work-related injuries for CSXT employees are primarily subject to the Federal Employers’ Liability Act (“FELA”). CSXT retains an independent actuary to assist management in assessing the value of personal injury claims. An analysis is performed by the actuary quarterly and is reviewed by management. This analysis did not result in a material adjustment to the personal injury reserve in the quarter ended March 31, 2020 or March 31, 2019. The methodology used by the actuary includes a development factor to reflect growth or reduction in the value of these personal injury claims based largely on CSXT's historical claims and settlement experience.

NOTE 4.    Casualty, Environmental and Other Reserves, continued

Occupational

Occupational reserves represent liabilities for occupational injury and disease claims. Occupational injury claims arise from allegations of exposure to certain materials in the workplace, such as solvents, soaps, chemicals (collectively referred to as “irritants”) and diesel fuels (like exhaust fumes) or allegations of chronic physical injuries resulting from work conditions, such as repetitive stress injuries. Occupational disease claims arise primarily from allegations of exposure to asbestos in the workplace. An analysis performed by management did not result in a material adjustment to the occupational reserve in the quarter ended March 31, 2020 or March 31, 2019.

Environmental

Environmental reserves were $77 million and $74 million as of March 31, 2020 and December 31, 2019, respectively. The Company is a party to various proceedings related to environmental issues, including administrative and judicial proceedings involving private parties and regulatory agencies. The Company has been identified as a potentially responsible party at approximately 220 environmentally impaired sites. Many of these are, or may be, subject to remedial action under the federal Comprehensive Environmental Response, Compensation and Liability Act of 1980 ("CERCLA"), also known as the Superfund Law, or similar state statutes. Most of these proceedings arose from environmental conditions on properties used for ongoing or discontinued railroad operations. A number of these proceedings, however, are based on allegations that the Company, or its predecessors, sent hazardous substances to facilities owned or operated by others for treatment, recycling or disposal. In addition, some of the Company's land holdings were leased to others for commercial or industrial uses that may have resulted in releases of hazardous substances or other regulated materials onto the property and could give rise to proceedings against the Company.

In any such proceedings, the Company is subject to environmental clean-up and enforcement actions under the Superfund Law, as well as similar state laws that may impose joint and several liability for clean-up and enforcement costs on current and former owners and operators of a site without regard to fault or the legality of the original conduct. These costs could be substantial.

In accordance with the Asset Retirement and Environmental Obligations Topic in the ASC, the Company reviews its role with respect to each site identified at least quarterly, giving consideration to a number of factors such as:

NOTE 4.    Casualty, Environmental and Other Reserves, continued

Based on the review process, the Company has recorded amounts to cover contingent anticipated future environmental remediation costs with respect to each site to the extent such costs are reasonably estimable and probable. The recorded liabilities for estimated future environmental costs are undiscounted. The liability includes future costs for remediation and restoration of sites as well as any significant ongoing monitoring costs, but excludes any anticipated insurance recoveries. Payments related to these liabilities are expected to be made over the next several years. Environmental remediation costs are included in materials, supplies and other on the consolidated income statements.

Currently, the Company does not possess sufficient information to reasonably estimate the amounts of additional liabilities, if any, on some sites until completion of future environmental studies. In addition, conditions that are currently unknown could, at any given location, result in additional exposure, the amount and materiality of which cannot presently be reasonably estimated. Based upon information currently available, however, the Company believes its environmental reserves accurately reflect the estimated cost of remedial actions currently required.

Other

Other reserves were $43 million and $44 million as of March 31, 2020 and December 31, 2019, respectively. These reserves include liabilities for various claims, such as property, automobile and general liability. Also included in other reserves are longshoremen disability claims related to a previously owned international shipping business (these claims are in runoff) as well as claims for current port employees.

NOTE 5.    Commitments and Contingencies

Insurance

The Company maintains insurance programs with substantial limits for property damage, including resulting business interruption, and third-party liability. A certain amount of risk is retained by the Company on each insurance program. During the quarter, the Company restructured its property insurance program to increase the level at which the Company retains all risk from $50 million to $100 million per occurrence for losses from floods and named windstorms and from $25 million to $75 million per occurrence for other property losses. For third-party liability claims, the Company retains all risk up to $75 million per occurrence. While the Company believes its insurance coverage is adequate, future claims could exceed existing insurance coverage or insurance may not continue to be available at commercially reasonable rates.

NOTE 5.    Commitments and Contingencies, continued

Legal

    The Company is involved in litigation incidental to its business and is a party to a number of legal actions and claims, various governmental proceedings and private civil lawsuits, including, but not limited to, those related to fuel surcharge practices, tax matters, environmental and hazardous material exposure matters, FELA and labor claims by current or former employees, other personal injury or property claims and disputes and complaints involving certain transportation rates and charges. Some of the legal proceedings include claims for compensatory as well as punitive damages and others are, or are purported to be, class actions. While the final outcome of these matters cannot be predicted with certainty, considering, among other things, the legal defenses available and liabilities that have been recorded along with applicable insurance, it is currently the opinion of management that none of these pending items is likely to have a material adverse effect on the Company's financial condition, results of operations or liquidity. An unexpected adverse resolution of one or more of these items, however, could have a material adverse effect on the Company's financial condition, results of operations or liquidity in that particular period.

The Company is able to estimate a range of possible loss for certain legal proceedings for which a loss is reasonably possible in excess of reserves established. The Company has estimated this range to be $1 million to $38 million in aggregate at March 31, 2020. This estimated aggregate range is based upon currently available information and is subject to significant judgment and a variety of assumptions. Accordingly, the Company's estimate will change from time to time, and actual losses may vary significantly from the current estimate.

Fuel Surcharge Antitrust Litigation

In May 2007, class action lawsuits were filed against CSXT and three other U.S.-based Class I railroads alleging that the defendants' fuel surcharge practices relating to contract and unregulated traffic resulted from an illegal conspiracy in violation of antitrust laws. The class action lawsuits were consolidated into one case in federal court in the District of Columbia. In 2017, the District Court issued its decision denying class certification. On August 16, 2019, the U.S. Court of Appeals for the D.C. Circuit affirmed the District Court’s ruling.

The District Court had delayed proceedings on the merits of the consolidated case pending the outcome of the class certification proceedings. The consolidated case is now moving forward without class certification. Because a class was not certified, shippers other than those who brought the original lawsuit in 2007 must decide whether to bring their own individual claim against one or more railroads. Some individual shippers have filed separate claims that have now been consolidated into a separate case.

CSXT believes that its fuel surcharge practices were arrived at and applied lawfully and that the case is without merit. Accordingly, the Company intends to defend itself vigorously. However, penalties for violating antitrust laws can be severe, and resolution of these matters individually or when aggregated could have a material adverse effect on the Company's financial condition, results of operations or liquidity in that particular period.

NOTE 5.    Commitments and Contingencies, continued

Environmental

CSXT is indemnifying Pharmacia LLC, formerly known as Monsanto Company, ("Pharmacia") for certain liabilities associated with real estate located in Kearny, New Jersey along the Lower Passaic River (the “Property”). The Property, which was formerly owned by Pharmacia, is now owned by CSXT. CSXT's indemnification and defense duties arise with respect to several matters. The U.S. Environmental Protection Agency ("EPA"), using its CERCLA authority, seeks the investigation and cleanup of hazardous substances in the 17-mile Lower Passaic River Study Area (the "Study Area”). CSXT, on behalf of Pharmacia, and a significant number of other potentially responsible parties are together conducting a Remedial Investigation and Feasibility Study of the Study Area pursuant to an Administrative Settlement Agreement and Order on Consent with the EPA. Pharmacia’s share of responsibility, indemnified by CSXT, for the investigation and cleanup costs of the Study Area may be determined through various mechanisms including (a) an allocation and settlement with EPA; (b) litigation brought by EPA against non-settling parties; or (c) litigation among the responsible parties.

In March 2016, EPA issued its Record of Decision detailing the agency’s mandated remedial process for the lower 8 miles of the Study Area. Approximately 80 parties, including Pharmacia, are participating in an EPA-directed allocation process to assign responsibility for costs to be incurred implementing the remedy selected for the lower 8 miles of the Study Area. CSXT is participating in the allocation process on behalf of Pharmacia. At a later date, EPA will select a remedy for the remainder of the Study Area and is expected to again seek the participation of private parties to implement the selected remedy using EPA’s CERCLA authority to compel such participation, if necessary.

CSXT is also defending and indemnifying Pharmacia with regard to the Property in litigation filed by Occidental Chemical Corporation ("Occidental"), which is seeking to recover various costs. These costs include costs for the remedial design of the lower 8 miles of the Study Area, as well as anticipated costs associated with the future remediation of the lower 8 miles of the Study Area and potentially the entire Study Area. Alternatively, Occidental seeks to compel some, or all of the defendants to participate in the remediation of the Study Area.  Pharmacia is one of approximately 110 defendants in this federal lawsuit filed by Occidental on June 30, 2018.

CSXT is also defending and indemnifying Pharmacia in a cooperative natural resource damages assessment process related to the Property. Based on currently available information, the Company does not believe any indemnification or remediation costs potentially allocable to CSXT with respect to the Property and the Study Area would be material to the Company's financial condition, results of operations or liquidity.

NOTE 6.    Employee Benefit Plans

The Company sponsors defined benefit pension plans principally for salaried, management personnel. Beginning in 2020, the CSX Pension Plan is closed to new participants.

CSX also sponsors a non-contributory post-retirement medical plan and a life insurance plan that provide certain benefits to eligible employees hired prior to January 1, 2003. Beginning in 2019, both the life insurance benefit for eligible active employees and health savings account contributions made by the Company to eligible retirees younger than 65 were eliminated. Beginning in 2020, the employer-funded health reimbursement arrangements for eligible retirees 65 years or older have been eliminated. Independent actuaries compute the amounts of liabilities and expenses relating to these plans subject to the assumptions that the Company determines are appropriate based on historical trends, current market rates and future projections. These amounts are reviewed by management.

Only the service cost component of net periodic benefit costs is included in labor and fringe expense on the consolidated income statement. All other components of net periodic benefit cost are included in other income - net.

    

Qualified pension plan obligations are funded in accordance with regulatory requirements and with an objective of meeting or exceeding minimum funding requirements necessary to avoid restrictions on flexibility of plan operation and benefit payments. No contributions to the Company's qualified pension plans are expected in 2020.

CSX CORPORATION

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS

(Unaudited)

NOTE 7.    Debt and Credit Agreements

Total activity related to long-term debt as of the end of first quarter 2020 is shown in the table below. For fair value information related to the Company's long-term debt, see Note 10, Fair Value Measurements.

Debt Issuance

On March 30, 2020, CSX issued $500 million of 3.8% notes due 2050. These notes are included in the consolidated balance sheets under long-term debt and may be redeemed by the Company at any time, subject to payment of certain make-whole premiums. The net proceeds will be used for general corporate purposes, which may include debt repayments, repurchases of CSX’s common stock, capital investment, working capital requirements, improvements in productivity and other cost reductions.

Credit Facility

CSX has a $1.2 billion unsecured, revolving credit facility backed by a diverse syndicate of banks. This facility allows same-day borrowings at floating interest rates, based on LIBOR or an agreed-upon replacement, plus a spread that depends upon CSX's senior unsecured debt ratings. LIBOR is the London Interbank Offered Rate which is a daily reference rate based on the interest rates at which banks offer to lend unsecured funds. This facility expires in March 2024, and at March 31, 2020, the Company had no outstanding balances under this facility.

Commitment fees and interest rates payable under the facility were similar to fees and rates available to comparably rated investment-grade borrowers. As of first quarter 2020, CSX was in compliance with all covenant requirements under this facility.

Commercial Paper

Under its commercial paper program, which is backed by the revolving credit facility, the Company may issue unsecured commercial paper notes up to a maximum aggregate principal amount of $1.0 billion outstanding at any one time. Proceeds from issuances of the notes are expected to be used for general corporate purposes. At March 31, 2020, the Company had no outstanding debt under the commercial paper program.